Prof. S. melamed, M.D. ,
    The Sam Rothberg Glaucoma Center
    Tel Aviv University Medical School
    Tel Aviv, Israel

    Selective Laser Trabeculoplasty (SLT) has been developed as an alternative to Argon Laser Trabeculoplasty. In Recent years this treatment modality has become the most accepted method of open angle glaucoma treatment.

    The advantages of SLT are the result of the specific targeting of Melanin Granules in the Trabecular Meshwork by the laser. It is a Double-Frequency Yag Laser with exposure time of 3 Nanoseconds, and there is no necrotic response of tissue as there is much less heat dissipation when compared with Argon Laser.
In recent 6 years, many investigators have reported their positive results with SLT, which included effective IOP reduction and less complications such as IOP spike and PAS formation.

    Due to its superb safety profile, we have studied the use of SLT as a primary treatment in 45 Glaucoma patients. The results of this study, along with the basic mechanisms of SLT will be thoroughly discussed.

    声明:本站独家报道，转载须标明来源“中华眼科在线”